Rhubarb-Based drug could be new hope for fatty liver
Disease control
Not yet recruiting
This study tests whether diacerein, a drug made from a compound found in rhubarb, can help treat metabolic fatty liver disease (MAFLD) in adults. About 74 adults aged 18 to 60 with MAFLD will receive either diacerein or a placebo to see if it reduces liver fat and improves liver …
Phase: NA • Sponsor: Hongyan Wu • Aim: Disease control
Last updated May 05, 2026 11:56 UTC